Publication | Closed Access

CT attenuation of liver metastases before targeted therapy is a prognostic factor of overall survival in colorectal cancer patients. Results from the randomised, open-label FIRE-3/AIO KRK0306 trial

HepatologyGastrointestinal OncologyMedicineHepatobiliary TumorCt AttenuationColorectal CancerColorectal Cancer PatientsLiver CancerTargeted TherapyOncologyRadiation OncologyRadiologyHealth Sciences